Condition: PBMCs · Sponsor: TCRx Therapeutics Co.Ltd
Peripheral Blood Mononuclear Cells (PBMC) are a mixed population of cells with a single nucleus found in peripheral blood (i.e., blood outside the bone marrow), including natural killer cells (NK), T lymphocytes (70% - 90%), and B lymphocytes. They can be further isolated and purified and are the main source of immune cells. This study will be conducted at our hospital, with a planned recruitment of 200 subjects. Subjects who meet the inclusion criteria and do not meet the exclusion criteria will have their peripheral blood mononuclear cells collected via apheresis. Each subject will need to provide an apheresis sample containing approximately 8×10\^9 mononuclear cells (with a sample volume of about 150 mL).
This description comes directly from the study's public registry record.
Weichi Zhou · +86 17368691876 · ksh-clinicalt@tcrximmune.com
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of Bengbu Medical University | Bengbu, Anhui, China | Suspended |
| The First Affiliated Hospital of Anhui Medical University | Hefei, Anhui, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07663565